| Literature DB >> 30197423 |
G Dell'Aversana Orabona1, A Romano1, V Abbate1, G Salzano1, P Piombino2,3, F Farina4, A Pansini1, G Iaconetta5, L Califano1.
Abstract
Septal deviations are the most frequent cause of nasal obstruction, and represent a common complaint in rhinologic practice. Since the first description of Lanza et al. in 1991, the use of the endoscope for the correction of septal deformities is increasingly more frequent. The purpose of this study is to evaluate the effectivenes of the endoscopic septoplasty for the correction of each of the 7 types of septal deformities according to the Mladina's classification. A retrospective chart review was performed in 59 consecutive patients presenting to our Department for Endoscopic Septoplasty from February 2012 to August 2014. For each deviation, descriptive statistics (mean and standard deviation, significant increase/decrease) was used to asses the corrective capacity and time-dependent effects at follow-up. This study shows that the corrective power of endoscopic septoplasty is different according to the type of deviation. To our knowledge this is the first study that evaluates the corrective capacity of this technique for each deviation by analysing pre- and postoperative objective outcomes as well as subjective outcomes gathered from the validated NOSE questionnaire. Even if endoscopic septoplasty may now be considered a reliable alternative to the classic technique, it is essential to identify the right deformity preoperatively in order to provide the correct therapeutic choice.Entities:
Keywords: Cottle‘s area; Endoscopic septoplasty; NOSE scale; Septal deformities; Septal deviation
Mesh:
Year: 2018 PMID: 30197423 PMCID: PMC6146582 DOI: 10.14639/0392-100X-1067
Source DB: PubMed Journal: Acta Otorhinolaryngol Ital ISSN: 0392-100X Impact factor: 2.124
Fig. 1.The seven types of septal deviations proposed by Mladina. In the first column, CT scans processed with OsiriX program are shown; the second column shows schematic illustrations for each deviation.
Classification proposed by Mladina.
| Unilateral vertical septal ridge in the valve region that does not reach the valve itself; it does not change the physiologic valve angle (15%) and therefore usually plays just a mild role in the nasal pathophysiology | |
| Unilateral vertical septal ridge in the valve region that touches the nasal valve, thus reducing the physiologic valve angle (15%) | |
| Unilateral vertical ridge that is located more deeply in the nasal cavity, opposite the head of the middle turbinate | |
| Bilateral deformity consisting of type 2 on one side and type 3 on the other | |
| Almost horizontal septal spur that sticks laterally and deeply into the nasal cavity. The opposite side of the nasal septum is always flat | |
| Massive unilateral intermaxillary bone wing with a “gutter” between it and the rest of the septum on this septal side. On the other septal side, there is an anteriorly positioned basal septal crest. | |
| Very variable combination of the previous types |
Fig. 2.Intraoperative picture showing: a) horizontal hemitransfixation incision parallel to the nasal floor on the apex of the septal spur; b) flaps elevation to expose the underlying bony or cartilaginous spur; c) 0° rigid nasal endoscope (4 mm), inserted between the mucoperichondrial flap and the septal cartilage; d) Cartilage excess resection without dislocating the vomero-chondral junction.
Fig. 3.The NOSE questionnaire.
Our cohort divided according to the Mladina classification. Disease-specific QOL scores (mean and standard deviation) assessed with the NOSE scale at baseline; 3 and 6 months after surgery.
| Deviation | Sample rate (%) | Baseline | 3 months | 6 months |
|---|---|---|---|---|
| I | 11.8% | 14.1 ± 1.2 | 12.3 ± 1.7 | 12.0 ± 1.9 |
| II | 13.5% | 16.0 ± 1.0 | 15.6 ± 1.0 | 15.5 ± 1.0 |
| III | 20.3% | 15.0 ± 0.8 | 14.5 ± 0.9 | 14.1 ± 0.6 |
| IV | 6.7% | 17.8 ± 0.5 | 11.0 ± 3.7 | 10.2 ± 3.3 |
| V | 23.7% | 18.1 ± 1.3 | 0.8 ± 0.4 | 0.7 ± 0.4 |
| VI | 18.6% | 17.6 ± 1.4 | 7.9 ± 7.7 | 7.7 ± 6.7 |
| VII | 5% | 16.6 ± 1.2 | 15.3 ± 0.6 | 15 ± 1.0 |
Wilcoxon non-parametric test to compare QOL scores registered at baseline, 3 and 6 months after surgery.
| Deviation | P-value | |
|---|---|---|
| I | T0 – T1 | 0.015 |
| II | T0 – T1 | 0.080 |
| III | T0 – T1 | 0.017 |
| IV | T0 – T1 | 0.046 |
| V | T0 – T1 | 0.000 |
| VI | T0 – T1 | 0.000 |
| VII | T0 – T1 | 0.057 |
T0: baseline; T1: follow up 3 months; T2: follow up 6 months.
**: < 0,05
***: < 0,01.
Fig. 4.Percentages decreased for each deviation type at 3 months, 6 months and overall.